Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.51NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.17NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.17NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.28NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.28NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.28NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XRNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XRNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XRNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.350.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.350.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.350.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.254NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.254NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.254NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.39.1.1 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.39.1.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.39.1.1 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.418NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.418NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.418NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.9.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.9.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.9.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.40NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.40NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.40NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.122NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.122NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.122NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XAJNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XAJNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAJNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.431NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.431NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.431NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.168NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.168NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.168NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Q.6 (Alpha)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1668.53US
Q.6 (Alpha)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Q.6 (Alpha)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-3660.47China
AZ.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AZ.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AZ.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.97NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.97NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.97NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.18NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used